United Therapeutics Corp (NASDAQ:UTHR)

Delayed Data
As of Feb 16
 -1.18 / -0.87%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 13 analysts offering 12-month price forecasts for United Therapeutics Corp have a median target of 118.00, with a high estimate of 232.00 and a low estimate of 95.00. The median estimate represents a -12.55% decrease from the last price of 134.93.

Analyst Recommendations

The current consensus among 13 polled investment analysts is to Hold stock in United Therapeutics Corp. This rating has held steady since February, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Feb 27

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -36.14%
Growthannually -16.45%


Growthquarterly -5.57%
Growthannually 4.99%
Key to the earnings and sales forecast charts.